frank@feplaw.com

frank@feplaw.com

Invokana Lawsuits

Final results from two independent clinical trials indicate the amputation risk for users of the Type 2 Diabetes drug Canagliflozin, marketed as Invokana, Invokamet, Invokamet XR, are much greater than previously understood. The FDA was so concerned about the information…